Stocks TelegraphStocks Telegraph
Stock Ideas

ARTL Stock Performance and Key Statistics

NASDAQ : ARTL

Artelo Biosciences

$4.85
-0.94-16.24%
At Close 4:00 PM
$4.02
−0.83-17.11%
After-Market 08:30 PM
60.16
BESG ScoreESG Rating

stock performance chart

ARTL Fundamental Analysis

Based on recent data, Artelo Biosciences, Inc. (ARTL) shows an Average True Range (ATR) of 0.15 and an Enterprise Value of 1.72M. Its average trading volume over the past 3 months is 1.3M, indicating liquidity. These fundamental metrics provide insight into ARTL's underlying financial health and market activity.

ATR0.15
Enterprise Value1.72M
Avg Vol (3 Months)1.3M
Avg Vol (10 Days)12.57M

ARTL Technical Analysis Indicators

Artelo Biosciences, Inc. (ARTL) technical indicators as of March 26, 2026: the SMA 20 is -10.12%, SMA 50 at -17.19%, and SMA 200 at -77.32%. The RSI 14 value is 41.44, suggesting its current momentum. These technical analysis signals help assess ARTL's price trends and potential future movements.

SMA 20-10.12%
SMA 50-17.19%
SMA 200-77.32%
RSI 1441.44

ARTL Stock Performance Overview

Artelo Biosciences, Inc. (ARTL) stock performance overview as of March 26, 2026: The 52-week high is $85.8 (currently -95.66% below), and the 52-week low is $3.15 (currently 12.73% above). Over the past year, ARTL's performance is -75.73%, compared to the S&P 500's 14.34% change.

52-Week High85.8
52-Week High Chg-95.66%
52-Week Low3.15
52-Week Low Chg+12.73%
S&P 500 52-Week Chg14.34%

Artelo Biosciences, Inc. (ARTL) Historical Stock Performance

According to market data, Artelo Biosciences, Inc. (ARTL) stock's recent performance metrics show that over the last month, ARTL is -8.79%, with a Year-to-Date (YTD) performance of 36.07%. Over the past year, the stock has seen a -75.73% change. These figures summarize ARTL's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High9.89.89.818.4885.89.8
Low4.243.153.153.153.153.15
Performance+18.57%-8.79%-60.38%-88.59%-75.73%+36.07%

Industry Analysis and Valuation

According to current financial data, ARTL stock's P/E (TTM) ratio is -0.97, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ARTL, including P/S (N/A), P/B (-9.81), and P/FCF (-1.14), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationARTLSector MedianIndustry AvgS&P 500
P/E (TTM)-0.97-1.23-5.1632.59
P/S (TTM)N/A3.71464.925.98
P/B (TTM)-9.817.624.774.62
P/FCF (TTM)-1.1472.79-221.0332.15

Frequently Asked Questions

How is ARTL price-to-earnings ratio currently?
ARTL has a current P/E ratio of -0.97
How are ARTL's price-to-sale and price-to-book ratios?
The ARTL stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is -9.81.
Is Artelo Biosciences, Inc.'s price-to-cashflow ratio high or low?
ARTL's price-to-free-cashflow (P/FCF) ratio is -1.14, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for ARTL?
Based on ARTL's recent bid, its distance from 20 days simple moving average is -10.12%. It is -17.19% apart from 50 days simple moving average, and it is -77.32% apart from 200 days simple moving average.
What is the 52-week price range for ARTL?
The 52-week high for ARTL is $85.80 which is -95.66% away from the current price level whereas the distance of that from the 52-week low of $3.15 stands at 12.73%.
An overview of ARTL's stock performance: how did it fare?
The performance of ARTL stock was not encouraging with most of its significant price indicators in green. Artelo Biosciences, Inc.(NASDAQ: ARTL) shares have moved downward -16.23% or - $0.94 in the latest trading session and have gained 36.07% year-to-date (YTD). The stock has lost nearly -75.73% over the past year. After moving -60.38% over the trailing 3-month period, the stock is -88.59% lower in the 6-month period. Looking at its performance over the shorter term, it'sgained 18.57% a week and -8.79% a month.
What is ARTL's 14-day relative strength index (RSI)?
The current 14-day RSI for ARTL stock is 41.44. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For ARTL, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Artelo Biosciences, Inc. (ARTL) has a 14-day ATR of 0.15.
What is ARTL's current enterprise value?
After closing at $5.79 with 2.12M of its shares outstanding, the current enterprise value of ARTL is roughly 1.72M.
Over the past year, how has the stock price of ARTL changed?
Artelo Biosciences, Inc. (NASDAQ: ARTL) is down -75.73% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 14.34%. ARTL stock price is also up 36.07% on its value in year-to-date trading.
What is the average trading volume for ARTL shares?
The number outstanding shares of ARTL is 2.12M, and of these 99.37% shares are freely available for trading. On average, ARTL stock has traded 12.57M shares per day for the past 10 days. A total of 3.2M shares changed hands during the last trading session with the average session volume of 1.25M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph